研究人员针对TDP1和CDK1酶,确定抗药性癌症的潜在新疗法。 Researchers identify potential new therapy for drug-resistant cancer by targeting TDP1 and CDK1 enzymes.

印度印度科学养殖协会的研究人员已经确定了抗药性癌症的潜在新疗法。 Researchers at India’s Indian Association for the Cultivation of Science have identified a potential new therapy for drug-resistant cancer. 他们的研究显示 癌症细胞激活DNA修复酶 TDP1 以存活现有治疗 Their study reveals that cancer cells activate the DNA repair enzyme TDP1 to survive existing treatments. 他们以TDP1和CDK1酶为对象,建议采用组合疗法,以提高治疗效力,破坏癌症细胞存活。 By targeting both TDP1 and the CDK1 enzyme, they propose a combination therapy that may enhance treatment effectiveness and disrupt cancer cell survival. 这种办法可导致抗性癌症精密药品的进步。 This approach could lead to advancements in precision medicine for resistant cancers.